These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6185234)

  • 1. The mechanism of cell surface changes of guinea pig macrophages activated with purified migration inhibitory factor/macrophage activation factor.
    Homma Y; Onozaki K; Fukutomi Y; Hashimoto T
    Cell Immunol; 1982 Sep; 72(2):231-8. PubMed ID: 6185234
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of cadmium, lead, and zinc on the ability of guinea pig macrophages to interact with macrophage migration inhibitory factor.
    Kiremidjian-Schumacher L; Stotzky G; Dickstein RA; Schwartz J
    Environ Res; 1981 Feb; 24(1):106-16. PubMed ID: 7011794
    [No Abstract]   [Full Text] [Related]  

  • 3. The mechanism of macrophage activation induced by Ca2+ ionophore.
    Onozaki K; Takenawa T; Homma Y; Hashimoto T
    Cell Immunol; 1983 Feb; 75(2):242-54. PubMed ID: 6403251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation and augmentation of guinea pig macrophages with streptococcal preparation OK-432 and stimulated spleen cell products.
    Onozaki K; Suzuki K; Fukutomi Y; Yagami K; Hashimoto T
    J Reticuloendothel Soc; 1982 Dec; 32(6):433-42. PubMed ID: 6761439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Macrophage activation by macrophage activation factor and macrophage migration inhibitory factor].
    Onozaki K
    Nihon Saikingaku Zasshi; 1985 Sep; 40(5):811-7. PubMed ID: 3908741
    [No Abstract]   [Full Text] [Related]  

  • 6. Increased responsiveness to macrophage-activating factor (MAF) after alteration of macrophage membranes.
    Piessens WF; Remold HG; David JR
    J Immunol; 1977 Jun; 118(6):2078-82. PubMed ID: 325137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracellular mediation of lymphokine action: mimicry of migration inhibitory factor (MIF) action by phorbol myristate acetate (PMA) and the ionophore A23187.
    Pick E; Seger M; Honig S; Griffel B
    Ann N Y Acad Sci; 1979; 332():378-94. PubMed ID: 231407
    [No Abstract]   [Full Text] [Related]  

  • 8. Modulation of macrophage functions by lymphokines.
    Sorg C
    Immunobiology; 1982 Apr; 161(3-4):352-60. PubMed ID: 6178679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage migration inhibition factor: interactions with calcium, magnesium, and cyclic AMP.
    Block LH; Aloni B; Biemesderfer D; Kashgarian M; Bitensky MW
    J Immunol; 1978 Oct; 121(4):1416-21. PubMed ID: 212481
    [No Abstract]   [Full Text] [Related]  

  • 10. Lymphokine-mediated fusion and migration inhibition of alveolar macrophages.
    Warfel AH; Hadden JW
    Exp Mol Pathol; 1980 Oct; 33(2):153-68. PubMed ID: 6998722
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of lymphokines in regulation of macrophage differentiation.
    Onozaki K; Akagawa KS; Haga S; Miura K; Hashimoto T; Tokunaga T
    Cell Immunol; 1983 Feb; 76(1):129-36. PubMed ID: 6339080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of an antibody against guinea pig MIF. III. Biological activity of MIF recovered from immunoadsorbent column chromatography.
    Onozaki K; Haga S; Ichikawa M; Homma Y; Miura K; Hashimoto T
    Cell Immunol; 1981 Jun; 61(1):165-75. PubMed ID: 7020954
    [No Abstract]   [Full Text] [Related]  

  • 13. Cytoskeletal control of concanavalin A receptor mobility in peritoneal macrophages.
    Pick E; Wilner I
    Exp Cell Res; 1979 Jan; 118(1):151-8. PubMed ID: 365553
    [No Abstract]   [Full Text] [Related]  

  • 14. Leukocyte inhibitory factor (LIF) potentiates human macrophage aggregation and activation responses to calcium ionophore A23187 and directly induces leukotriene B4 and thromboxane A2 release.
    Conti P; Barbacane RC; Reale M; Panara MR; Placido FC; Mier JW; Castracane JM; Dempsey RA
    Biotechnol Ther; 1993; 4(3-4):239-52. PubMed ID: 8292972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble lymphocytic mediators. I. Inhibition of macrophage migration inhibitory factor production by drugs.
    Pick E
    Immunology; 1974 Mar; 26(3):649-58. PubMed ID: 4369184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of macrophage activation on the response to migration inhibitory factor (MIF).
    Leu RW; Woodson PD; Whitley SB
    J Reticuloendothel Soc; 1977 Oct; 22(4):329-40. PubMed ID: 336882
    [No Abstract]   [Full Text] [Related]  

  • 17. The mechanism of action of soluble lymphocyte mediators. V. Mechanism of refractoriness to adenylate cyclase stimulators induced by migration inhibitory factor (MIF).
    Pick E; Grunspan-Swirsky A
    Cell Immunol; 1977 Aug; 32(2):340-9. PubMed ID: 198145
    [No Abstract]   [Full Text] [Related]  

  • 18. The mechanism of action of soluble lymphocyte mediators. IV. Effect of migratio inhibitory factor (MIF) on macrophage cyclic AMP and on responsiveness to adenylate cyclase stimulators.
    Pick E
    Cell Immunol; 1977 Aug; 32(2):329-39. PubMed ID: 198144
    [No Abstract]   [Full Text] [Related]  

  • 19. Regulatory mechanisms of cutaneous delayed-type hypersensitivity. I. Suppression of cutaneous delayed-type hypersensitivity by migration inhibitory factor.
    Mizushima A; Baba T; Ochiya T; Yamaguchi K; Onozaki K; Yaoita H; Uyeno K
    Cell Immunol; 1983 Oct; 81(1):126-33. PubMed ID: 6352055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphokines: mediators of delayed hypersensitivity.
    Rocklin RE
    Prog Clin Biol Res; 1981; 58():7-12. PubMed ID: 7022482
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.